We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Avoiding Critical Errors in Blood Gas Testing

By LabMedica International staff writers
Posted on 14 Nov 2012
Print article
Image: Smartphone's start test, handbook, and arterial puncture guide (Photo courtesy of Radiometer Medical).
Image: Smartphone's start test, handbook, and arterial puncture guide (Photo courtesy of Radiometer Medical).
Avoiding preanalytical errors in blood gas testing should ensure that healthcare providers receive information on the spot. This would help avoid critical errors in blood gas testing.

The “avoid preanalytical errors” app from Radiometer Medical (Copenhagen, Denmark) focuses on the most typical preanalytical errors in blood gas testing and what operators can do to avoid them. The app is available for iPhone, Windows Phone, and Android and includes tips on how to avoid errors, troubleshooting and a skill test. The troubleshooting section is a helpful tool when you are experiencing difficulties evaluating if measured results reflect patient status or if a preanalytical error may have occurred. A handbook explains how to avoid errors, with video demonstrations of the correct procedure for performing an arterial puncture, arterial line, or capillary sampling. To view the app content please see Related Links below.

Ana-Maria Simundic, PhD, assistant professor, clinical chemistry specialist and president of the Croatian Society for Medical Biochemistry and Laboratory Medicine, commented: “Up to 75% of all testing errors occur in the preanalytical phase. The variation in test results can be detrimental to the patients, as clinicians base the treatment strategies on the test results. The best way to ensure patient safety–and save time and money–is to understand the challenges of preanalytical variables, helping to proactively reduce some of the evitable errors by doing blood gas testing correctly the first time.”

Related Links:

Radiometer Medical
View Radiometer app content


Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Malaria Test
STANDARD Q Malaria P.f/Pan Ag
New
Centromere B Assay
Centromere B Test

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.